The Association Between Epidermal Growth Factor rs3756261 A/G Gene Polymorphism and the Risk of Ankylosing Spondylitis in a Chinese Han Population
Hui Zhang,Wei Jiang
DOI: https://doi.org/10.2147/ijgm.s448976
IF: 2.145
2024-03-28
International Journal of General Medicine
Abstract:Hui Zhang, Wei Jiang Department of Orthopedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, People's Republic of China Correspondence: Wei Jiang, Email Background: Epidermal growth factor (EGF) is a potent pro-angiogenic molecule promoting the angiogenic phenotype of ankylosing spondylitis (AS). Studies demonstrated that EGF rs3756261 polymorphism was associated with the risk of inflammatory diseases, but not including AS. Methods: To investigate the association between EGF rs3756261 polymorphism and the risk of AS, we genotyped the EGF rs3756261 polymorphism in 208 patients with AS and 412 controls in a Chinese Han population using a custom-by-design 48-Plex SNP scan TM Kit. The serum EGF levels were measured using an enzyme-linked immunosorbent assay in 208 AS patients and 412 controls. Results: Our data indicated that EGF rs3756261 polymorphism was associated with an increased risk of AS in the Chinese Han population. Stratified analyses indicated that the EGF rs3756261 polymorphism elevated the risk of AS among the males, smokers, drinkers and those aged < 30 years. In addition, the EGF rs3756261 polymorphism was related to increased CRP and HLA-B27 levels in AS patients. Next, we found that the average serum levels of EGF were significantly higher in AS patients compared with controls. Meanwhile, EGF serum levels were significantly higher in AG genotype carriers when compared with AA genotype carriers in AS patients. Conclusion: In conclusion, this study indicated that EGF rs3756261 polymorphism was associated with the risk of AS and EGF serum levels in a Chinese Han population. Keywords: EGF, rs3756261 polymorphism, serum levels, ankylosing spondylitis, case–control study Ankylosing spondylitis (AS) is an inflammatory disease characterized by the clinical features of back pain and stiffness. It is caused by chronic inflammatory disorders, manifested as pathological bone formation, joint and stiffness of spine, spine fibrosis, leading to spine deformity, even disability. 1–3 The morbidity of AS is high in young adults aged 18–22 years, especially the men. 4 However, the pathogenesis of AS is not yet clear. Genetic factors play major roles in AS pathogenesis. 5–8 Among all relevant genes, HLA-B27 is the most important genetic factor. 9 Other susceptibility genes (such as endoplasmic reticulum aminopeptidase-1 and mevalonate kinase) have also been reported. 10,11 Epidermal growth factor (EGF) is a powerful mitogen that activates DNA synthesis and cellular differentiation via mitogen-activated protein kinases (MAPKs) and other pathways. 12,13 EGF is involved in angiogenesis in epidermal tissue. 14,15 Studies have shown that a rapid decrease in salivary EGF levels can cause progression of the intraoral manifestations of Sjögren's syndrome. 16,17 In rheumatoid arthritis (RA) patients, high EGF levels were found in the synovial fluid, suggesting the involvement of EGF in the pathogenesis of arthritic diseases. 18,19 EGF and epidermal growth factor receptor (EGFR) can be downregulated by dioscin, which exerts anti-inflammatory activity by regulating the c-Jun N-terminal kinase (JNK) signaling pathway. 20 In the existing literature, a variety of EGF polymorphisms have been reported to be associated with etiology of inflammatory diseases. For instance, Wang et al revealed that EGF rs11568835 G/A polymorphism was associated with susceptibility to RA. 21 A study of EGF gene rs11568943 and rs2237051 polymorphisms found no evidence of a haplotype association with psoriatic arthritis (PsA). 22 Although EGF plays an important role in the immune response, no studies have examined the influence of the EGF rs3756261 A/G polymorphism on the susceptibility to AS. Functional variations in EGF gene may contribute to the development of AS. 23 Here, we designed this case–control study to assess the association of the EGF rs3756261 polymorphism and AS risk in a Chinese Han population. In this case–control study, 208 AS patients and 412 sex- and age-matched controls were consecutively recruited from the Changzhou Second Hospital-Affiliated Hospital of Nanjing Medical University (Changzhou, China), between September 2014 and January 2018. A diagnosis of AS was established by using the classification criteria reported by the American College of Rheumatology (Modified New York Criteria). 24 The controls were individuals receiving health examinations without AS, matched AS for age and sex, and recruited from the same institut -Abstract Truncated-
medicine, general & internal